|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
4
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L, Kunkler I, et al: EUROCARE-4 Working
Group: Recent cancer survival in Europe: A 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomas G: Furin at the cutting edge: From
protein traffic to embryogenesis and disease. Nat Rev Mol Cell
Biol. 3:753–766. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rhee JS and Coussens LM: RECKing MMP
function: Implications for cancer development. Trends Cell Biol.
12:209–211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmad R, Shihab PK, Jasem S and Behbehani
K: FSL-1 induces MMP-9 production through TLR-2 and NF-κB/AP-1
signaling pathways in monocytic THP-1 cells. Cell Physiol Biochem.
34:929–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang CQ, Li W, Li SQ, Li J, Li YW, Kong
SX, Liu RM, Wang SM and Lv WM: MCP-1 stimulates MMP-9 expression
via ERK 1/2 and p38 MAPK signaling pathways in human aortic smooth
muscle cells. Cell Physiol Biochem. 34:266–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng X, Yang Y, Fan Z, Yu L, Bai H, Zhou
B, Wu X, Xu H, Fang M, Shen A, et al: MKL1 potentiates lung cancer
cell migration and invasion by epigenetically activating MMP9
transcription. Oncogene. 34:5570–5581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sreekumar R, Sayan BS, Mirnezami AH and
Sayan AE: MicroRNA control of invasion and metastasis pathways.
Front Genet. 2:582011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia H and Hui KM: MicroRNAs involved in
regulating epithelial-mesenchymal transition and cancer stem cells
as molecular targets for cancer therapeutics. Cancer Gene Ther.
19:723–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an
oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song L, Turkson J, Karras JG, Jove R and
Haura EB: Activation of Stat3 by receptor tyrosine kinases and
cytokines regulates survival in human non-small cell carcinoma
cells. Oncogene. 22:4150–4165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu F, Zhang T, Zou S, Jiang B and Hua D:
B7-H3 promotes cell migration and invasion through the
Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Mol Med
Rep. 12:5455–5460. 2015.PubMed/NCBI
|
|
17
|
Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ,
He WF, Zhou YS, Liao GY, Li QP, Xiao SJ and Cai JZ: Fuzheng Kang'ai
decoction combined with gefitinib in advanced non-small cell lung
cancer patients with epidermal growth factor receptor mutations:
Study protocol for a randomized controlled trial. Trials.
16:1462015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu WY, Yang XB, Deng H, Long SQ, Sun LS,
He WF, Zhou YS, Liao GY, Chan SM and Shan SP: Treatment of advanced
non-small cell lung cancer with extracorporeal high frequency
thermotherapy combined with Chinese medicine. Chin J Integr Med.
16:406–410. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang XB, Wu WY, Long SQ, Deng H and Pan
ZQ: Effect of gefitinib plus Chinese herbal medicine (CHM) in
patients with advanced non-small-cell lung cancer: A retrospective
case-control study. Complement Ther Med. 22:1010–1018. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng F, Wu J, Li X, Tang Q, Yang L, Yang
X, Wu W and Hann SS: Chinese Herbal Medicine Fuzheng Kang-Ai
Decoction inhibited lung cancer cell growth through AMPKα-mediated
induction and interplay of IGFBP1 and FOXO3a. Evid Based Complement
Alternat Med. 2016:50607572016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: Moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development and disease. J Cell Biol. 172:973–981. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lui VW, Wong EY, Ho Y, Hong B, Wong SC,
Tao Q, Choi GC, Au TC, Ho K, Yau DM, et al: STAT3 activation
contributes directly to Epstein-Barr virus-mediated invasiveness of
nasopharyngeal cancer cells in vitro. Int J Cancer. 125:1884–1893.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo K, Ma Q, Li J, Wang Z, Shan T, Li W,
Xu Q and Xie K: Interaction of the sympathetic nerve with
pancreatic cancer cells promotes perineural invasion through the
activation of STAT3 signaling. Mol Cancer Ther. 12:264–273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El-Badrawy MK, Yousef AM, Shaalan D and
Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung
cancer patients and its relation to serum mmp-9 activity,
pathologic type, and prognosis. J Bronchology Interv Pulmonol.
21:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vilen ST, Salo T, Sorsa T and Nyberg P:
Fluctuating roles of matrix metalloproteinase-9 in oral squamous
cell carcinoma. ScientificWorldJournal. 2013:9205952013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Backstrom JR and Tökés ZA: The 84-kDa form
of human matrix metalloproteinase-9 degrades substance P and
gelatin. J Neurochem. 64:1312–1318. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu H and Jove R: The STATs of cancer-new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ao N and Liu Y, Bian X, Feng H and Liu Y:
Ubiquitin-specific peptidase 22 inhibits colon cancer cell invasion
by suppressing the signal transducer and activator of transcription
3/matrix metalloproteinase 9 pathway. Mol Med Rep. 12:2107–2113.
2015.PubMed/NCBI
|
|
31
|
Shirakihara T, Saitoh M and Miyazono K:
Differential regulation of epithelial and mesenchymal markers by
deltaEF1 proteins in epithelial mesenchymal transition induced by
TGF-beta. Mol Biol Cell. 18:3533–3544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Orlichenko LS and Radisky DC: Matrix
metalloproteinases stimulate epithelial-mesenchymal transition
during tumor development. Clin Exp Metastasis. 25:593–600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
